Posted by Michael Wonder on 21 Sep 2024
FTC accuses drug middlemen of inflating insulin prices
20 September 2024 - Agency files lawsuit alleging firms profited from higher insulin prices.
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the price of insulin.
